214 related articles for article (PubMed ID: 9178766)
1. The carboxy terminus of p53 mimics the polylysine effect of protein kinase CK2-catalyzed MDM2 phosphorylation.
Guerra B; Götz C; Wagner P; Montenarh M; Issinger OG
Oncogene; 1997 Jun; 14(22):2683-8. PubMed ID: 9178766
[TBL] [Abstract][Full Text] [Related]
2. Phage-peptide display identifies the interferon-responsive, death-activated protein kinase family as a novel modifier of MDM2 and p21WAF1.
Burch LR; Scott M; Pohler E; Meek D; Hupp T
J Mol Biol; 2004 Mar; 337(1):115-28. PubMed ID: 15001356
[TBL] [Abstract][Full Text] [Related]
3. Protein p21(WAF1/CIP1) is phosphorylated by protein kinase CK2 in vitro and interacts with the amino terminal end of the CK2 beta subunit.
Romero-Oliva F; Allende JE
J Cell Biochem; 2001; 81(3):445-52. PubMed ID: 11255227
[TBL] [Abstract][Full Text] [Related]
4. Status of p53 phosphorylation and function in sensitive and resistant human cancer models exposed to platinum-based DNA damaging agents.
Mujoo K; Watanabe M; Nakamura J; Khokhar AR; Siddik ZH
J Cancer Res Clin Oncol; 2003 Dec; 129(12):709-18. PubMed ID: 14513366
[TBL] [Abstract][Full Text] [Related]
5. Phosphorylation of murine double minute clone 2 (MDM2) protein at serine-267 by protein kinase CK2 in vitro and in cultured cells.
Hjerrild M; Milne D; Dumaz N; Hay T; Issinger OG; Meek D
Biochem J; 2001 Apr; 355(Pt 2):347-56. PubMed ID: 11284721
[TBL] [Abstract][Full Text] [Related]
6. p21WAF1/CIP1 interacts with protein kinase CK2.
Götz C; Wagner P; Issinger OG; Montenarh M
Oncogene; 1996 Jul; 13(2):391-8. PubMed ID: 8710378
[TBL] [Abstract][Full Text] [Related]
7. Wild-type p53 inhibits protein kinase CK2 activity.
Schuster N; Götz C; Faust M; Schneider E; Prowald A; Jungbluth A; Montenarh M
J Cell Biochem; 2001; 81(1):172-83. PubMed ID: 11180407
[TBL] [Abstract][Full Text] [Related]
8. The carboxy-terminal serine 392 phosphorylation site of human p53 is not required for wild-type activities.
Fiscella M; Zambrano N; Ullrich SJ; Unger T; Lin D; Cho B; Mercer WE; Anderson CW; Appella E
Oncogene; 1994 Nov; 9(11):3249-57. PubMed ID: 7936649
[TBL] [Abstract][Full Text] [Related]
9. The effect of polylysine on casein-kinase-2 activity is influenced by both the structure of the protein/peptide substrates and the subunit composition of the enzyme.
Meggio F; Boldyreff B; Marin O; Marchiori F; Perich JW; Issinger OG; Pinna LA
Eur J Biochem; 1992 May; 205(3):939-45. PubMed ID: 1577011
[TBL] [Abstract][Full Text] [Related]
10. p21(Waf1/Cip1) expression and the p53/MDM2 feedback loop in gastric carcinogenesis.
Craanen ME; Blok P; Offerhaus GJ; Meijer GA; Dekker W; Kuipers EJ; Meuwissen SG
J Pathol; 1999 Dec; 189(4):481-6. PubMed ID: 10629547
[TBL] [Abstract][Full Text] [Related]
11. Dual effect of lysine-rich polypeptides on the activity of protein kinase CK2.
Romero-Oliva F; Jacob G; Allende JE
J Cell Biochem; 2003 May; 89(2):348-55. PubMed ID: 12704797
[TBL] [Abstract][Full Text] [Related]
12. Identification of a CK2 phosphorylation site in mdm2.
Götz C; Kartarius S; Scholtes P; Nastainczyk W; Montenarh M
Eur J Biochem; 1999 Dec; 266(2):493-501. PubMed ID: 10561590
[TBL] [Abstract][Full Text] [Related]
13. Regulation of p53 mediated transactivation by the beta-subunit of protein kinase CK2.
Schuster N; Prowald A; Schneider E; Scheidtmann KH; Montenarh M
FEBS Lett; 1999 Mar; 447(2-3):160-6. PubMed ID: 10214938
[TBL] [Abstract][Full Text] [Related]
14. Binding domain for p21(WAF1) on the polypeptide chain of the protein kinase CK2 beta-subunit.
Götz C; Kartarius S; Scholtes P; Montenarh M
Biochem Biophys Res Commun; 2000 Feb; 268(3):882-5. PubMed ID: 10679299
[TBL] [Abstract][Full Text] [Related]
15. HMG-CoA reductase inhibitors, statins, induce phosphorylation of Mdm2 and attenuate the p53 response to DNA damage.
Pääjärvi G; Roudier E; Crisby M; Högberg J; Stenius U
FASEB J; 2005 Mar; 19(3):476-8. PubMed ID: 15625077
[TBL] [Abstract][Full Text] [Related]
16. p53 expression in CMV-infected cells: association with the alternative expression of the p53 transactivated genes p21/WAF1 and MDM2.
García JF; Piris MA; Lloret E; Orradre JL; Murillo PG; Martínez JC
Histopathology; 1997 Feb; 30(2):120-5. PubMed ID: 9067734
[TBL] [Abstract][Full Text] [Related]
17. MDM2 and p21WAF1/CIP1, wild-type p53-induced proteins, are regularly expressed by Sternberg-Reed cells in Hodgkin's disease.
Sánchez-Beato M; Piris MA; Martínez-Montero JC; García JF; Villuendas R; García FJ; Orradre JL; Martínez P
J Pathol; 1996 Sep; 180(1):58-64. PubMed ID: 8943816
[TBL] [Abstract][Full Text] [Related]
18. A novel system to investigate the phosphorylation of the p53 tumor suppressor protein by the protein kinase CK2.
McKendrick L; Meek DW
Cell Mol Biol Res; 1994; 40(5-6):555-61. PubMed ID: 7735330
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of 15-lipoxygenase-1 induces growth arrest through phosphorylation of p53 in human colorectal cancer cells.
Kim JS; Baek SJ; Bottone FG; Sali T; Eling TE
Mol Cancer Res; 2005 Sep; 3(9):511-7. PubMed ID: 16179498
[TBL] [Abstract][Full Text] [Related]
20. Mapping of the interaction sites of the growth suppressor protein p53 with the regulatory beta-subunit of protein kinase CK2.
Appel K; Wagner P; Boldyreff B; Issinger OG; Montenarh M
Oncogene; 1995 Nov; 11(10):1971-8. PubMed ID: 7478515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
